Related references
Note: Only part of the references are listed.Recent advances in the detection of respiratory virus infection in humans
Naru Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Emerging Viruses without Borders: The Wuhan Coronavirus
Shan-Lu Liu et al.
VIRUSES-BASEL (2020)
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies
Shibo Jiang et al.
EMERGING MICROBES & INFECTIONS (2020)
Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A
Ruben J. G. Hulswit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas
Danielle R. Adney et al.
VIRUSES-BASEL (2019)
Current epidemiological status of Middle East respiratory syndrome coronavirus in the world from 1.1.2017 to 17.1.2018: a cross-sectional study
Kazhal Mobaraki et al.
BMC INFECTIOUS DISEASES (2019)
Structural basis for human coronavirus attachment to sialic acid receptors
M. Alejandra Tortorici et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
MERS Coronavirus: An Emerging Zoonotic Virus
Fang Li et al.
VIRUSES-BASEL (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
Yusen Zhou et al.
VIRUSES-BASEL (2019)
Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges
Heeyoun Cho et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Changes to taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2018)
Andrew M. Q. King et al.
ARCHIVES OF VIROLOGY (2018)
Human coronavirus circulation in the United States 2014-2017
Marie E. Killerby et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
Receptor Usage of a Novel Bat Lineage C Betacoronavirus Reveals Evolution of Middle East Respiratory Syndrome-Related Coronavirus Spike Proteins for Human Dipeptidyl Peptidase 4 Binding
Susanna K. P. Lau et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Discovery of Novel Bat Coronaviruses in South China That Use the Same Receptor as Middle East Respiratory Syndrome Coronavirus
Chu-Ming Luo et al.
JOURNAL OF VIROLOGY (2018)
Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen
Mun Peak Nyon et al.
VACCINE (2018)
Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
Fan Luo et al.
VIROLOGICA SINICA (2018)
Prospects for a MERS-CoV spike vaccine
Yusen Zhou et al.
EXPERT REVIEW OF VACCINES (2018)
CD8+T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice
Svenja Veit et al.
VIRUSES-BASEL (2018)
MERS-CoV spike protein: a key target for antivirals
Lanying Du et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants
Wanbo Tai et al.
JOURNAL OF VIROLOGY (2017)
MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques
Chong Wang et al.
ONCOTARGET (2017)
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Jesper Pallesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein
Wentao Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection
Lan Jiaming et al.
VACCINE (2017)
Human Coronavirus in the 2014 Winter Season as a Cause of Lower Respiratory Tract Infection
Kyu Yeun Kim et al.
YONSEI MEDICAL JOURNAL (2017)
MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis
Vineet D. Menachery et al.
MBIO (2017)
Crystal structure of the receptor binding domain of the spike glycoprotein of human betacoronavirus HKU1
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2017)
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
Yuan Yuan et al.
NATURE COMMUNICATIONS (2017)
Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein
Sawsan S. Al-amri et al.
SCIENTIFIC REPORTS (2017)
Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection
Yufei Wang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus
Ben Hu et al.
PLOS PATHOGENS (2017)
Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus
Naru Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
Bart L. Haagmans et al.
SCIENCE (2016)
Vaccines for the prevention against the threat of MERS-CoV
Lanying Du et al.
EXPERT REVIEW OF VACCINES (2016)
A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection
Wanbo Tai et al.
VIROLOGY (2016)
Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines
Lanying Du et al.
NATURE COMMUNICATIONS (2016)
Structure, Function, and Evolution of Coronavirus Spike Proteins
Fang Li
ANNUAL REVIEW OF VIROLOGY, VOL 3 (2016)
Middle East respiratory syndrome: current status and future prospects for vaccine development
Lanying Du et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Detection of the Human Coronavirus 229E, HKU1, NL63, and OC43 between 2010 and 2013 in Yamagata, Japan
Yohei Matoba et al.
JAPANESE JOURNAL OF INFECTIOUS DISEASES (2015)
Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro) IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS
Sakshi Tomar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Human Coronavirus HKU1 Spike Protein Uses O-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme
Xingchuan Huang et al.
JOURNAL OF VIROLOGY (2015)
Detection of Murine Herpesvirus 68 (MHV-68) in Dermacentor reticulatus Ticks
Marcela Kudelova et al.
MICROBIAL ECOLOGY (2015)
Receptor-binding domain-based subunit vaccines against MERS-CoV
Naru Zhang et al.
VIRUS RESEARCH (2015)
Origin, Evolution, and Virulence of Porcine Deltacoronaviruses in the United States
Yuanmei Ma et al.
MBIO (2015)
Evaluation of candidate vaccine approaches for MERS-CoV
Lingshu Wang et al.
NATURE COMMUNICATIONS (2015)
Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus
Jian Tang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge
Jiaming Lan et al.
EBIOMEDICINE (2015)
Receptor Recognition Mechanisms of Coronaviruses: a Decade of Structural Studies
Fang Li
JOURNAL OF VIROLOGY (2015)
Accessory proteins of SARS-CoV and other coronaviruses
Ding Xiang Liu et al.
ANTIVIRAL RESEARCH (2014)
Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS
Jan Felix Drexler et al.
ANTIVIRAL RESEARCH (2014)
Current advancements and potential strategies in the development of MERS-CoV vaccines
Naru Zhang et al.
EXPERT REVIEW OF VACCINES (2014)
Crystal Structure of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Papain-like Protease Bound to Ubiquitin Facilitates Targeted Disruption of Deubiquitinating Activity to Demonstrate Its Role in Innate Immune Suppression
Ben A. Bailey-Elkin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Discovery of a Novel Bottlenose Dolphin Coronavirus Reveals a Distinct Species of Marine Mammal Coronavirus in Gammacoronavirus
Patrick C. Y. Woo et al.
JOURNAL OF VIROLOGY (2014)
Evidence for Camel-to-Human Transmission of MERS Coronavirus
Esam I. Azhar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen
Jiaming Lan et al.
PLOS ONE (2014)
Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus
Yang Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments-The importance of immunofocusing in subunit vaccine design
Cuiqing Ma et al.
VACCINE (2014)
Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
Cuiqing Ma et al.
VACCINE (2014)
An update on feline infectious peritonitis: Virology and immunopathogenesis
Niels C. Pedersen
VETERINARY JOURNAL (2014)
The Amino Acids 736-761 of the MERS-CoV Spike Protein Induce Neutralizing Antibodies: Implications for the Development of Vaccines and Antiviral Agents
Yang Yang et al.
VIRAL IMMUNOLOGY (2014)
Coronavirus virulence genes with main focus on SARS-CoV envelope gene
Marta L. De Diego et al.
VIRUS RESEARCH (2014)
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
Lu Lu et al.
NATURE COMMUNICATIONS (2014)
Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate
Wen-Hsiang Chen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
Nianshuang Wang et al.
CELL RESEARCH (2013)
Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC
Lanying Du et al.
JOURNAL OF INFECTION (2013)
A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC
Shibo Jiang et al.
JOURNAL OF INFECTION (2013)
The Acetyl-Esterase Activity of the Hemagglutinin-Esterase Protein of Human Coronavirus OC43 Strongly Enhances the Production of Infectious Virus
Marc Desforges et al.
JOURNAL OF VIROLOGY (2013)
The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies
Huihui Mou et al.
JOURNAL OF VIROLOGY (2013)
Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development
Lanying Du et al.
JOURNAL OF VIROLOGY (2013)
Crystal Structure of the Receptor-Binding Domain from Newly Emerged Middle East Respiratory Syndrome Coronavirus
Yaoqing Chen et al.
JOURNAL OF VIROLOGY (2013)
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
Chantal B. E. M. Reusken et al.
LANCET INFECTIOUS DISEASES (2013)
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Xing-Yi Ge et al.
NATURE (2013)
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Guangwen Lu et al.
NATURE (2013)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
Lanying Du et al.
PLOS ONE (2013)
Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus
Trevor Scobey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit Vaccine Candidates
Jie Li et al.
VIRAL IMMUNOLOGY (2013)
Detection of Coronaviruses in Bats of Various Species in Italy
Davide Lelli et al.
VIRUSES-BASEL (2013)
Human Betacoronavirus 2c EMC/2012-related Viruses in Bats, Ghana and Europe
Augustina Annan et al.
EMERGING INFECTIOUS DISEASES (2013)
Receptor-binding domain as a target for developing SARS vaccines
Xiaojie Zhu et al.
JOURNAL OF THORACIC DISEASE (2013)
Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome
Shibo Jiang et al.
EXPERT REVIEW OF VACCINES (2012)
Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavirus
Patrick C. Y. Woo et al.
JOURNAL OF VIROLOGY (2012)
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Ali Moh Zaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing
Hatem A. Elshabrawy et al.
PLOS ONE (2012)
Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans
Sander van Boheemen et al.
MBIO (2012)
Developments of subunit and VLP vaccines against influenza a virus
Ma-ping Deng et al.
VIROLOGICA SINICA (2012)
A 219-mer CHO-Expressing Receptor-Binding Domain of SARS-CoV S Protein Induces Potent Immune Responses and Protective Immunity
Lanying Du et al.
VIRAL IMMUNOLOGY (2010)
Peptide Nanoparticles as Novel Immunogens: Design and Analysis of a Prototypic Severe Acute Respiratory Syndrome Vaccine
Tais A. P. F. Pimentel et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Comparative Analysis of Complete Genome Sequences of Three Avian Coronaviruses Reveals a Novel Group 3c Coronavirus
Patrick C. Y. Woo et al.
JOURNAL OF VIROLOGY (2009)
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
Lanying Du et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice
Nuoyan Zheng et al.
VACCINE (2009)
Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity
Lanying Du et al.
VIROLOGY (2009)
More and More Coronaviruses: Human Coronavirus HKU1
Patrick C. Y. Woo et al.
VIRUSES-BASEL (2009)
Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a US Metropolitan Population
Emily G. Severance et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
A line immunoassay utilizing recombinant nucleocapsid proteins for detection of antibodies to human coronaviruses
Christian Lehmann et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2008)
Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections
Fang Li
JOURNAL OF VIROLOGY (2008)
Viral etiology of acute respiratory infections with cough in infancy - A community-based birth cohort study
Nicolas Regamey et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Development of subunit vaccines against severe acute respiratory syndrome
Lanying Du et al.
DRUGS OF TODAY (2008)
Seroepidemiology of group I human coronaviruses in children
Xiuping Shao et al.
JOURNAL OF CLINICAL VIROLOGY (2007)
Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
Lanying Du et al.
VACCINE (2007)
Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients
Giuseppe Gerna et al.
JOURNAL OF CLINICAL VIROLOGY (2007)
Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a Western blot assay for detection of human antibodies against HCoV-OC43
Thomas Mourez et al.
JOURNAL OF VIROLOGICAL METHODS (2007)
Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII- dependent entry into B cells in vitro
Yin Wing Kam et al.
VACCINE (2007)
Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: Implications for a subunit vaccine
Alexander N. Zakhartchouk et al.
VACCINE (2007)
Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors
Heike Hofmann et al.
JOURNAL OF VIROLOGY (2006)
Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients
G Gerna et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Coronavirus HKU1 and other coronavirus infections in Hong Kong
Susanna K. P. Lau et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: Implication for vaccine design
Yuxian He et al.
JOURNAL OF VIROLOGY (2006)
A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity
YX He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein
Yuxian He et al.
JOURNAL OF IMMUNOLOGY (2006)
Coronavirus HKU1 infection in the United States
F Esper et al.
EMERGING INFECTIOUS DISEASES (2006)
Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates
SJ Liu et al.
VACCINE (2006)
Influence of intron and exon splicing enhancers on mammalian cell expression of a truncated spike protein of SARS-CoV and its implication for subunit vaccine development
CY Chang et al.
VACCINE (2006)
Bats are natural reservoirs of SARS-like coronaviruses
WD Li et al.
SCIENCE (2005)
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
F Li et al.
SCIENCE (2005)
Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats
RY Liu et al.
VIRUS RESEARCH (2005)
Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus
YX He et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Elicitation of immunity in mice after immunization with the S2 subunit of the severe acute respiratory syndrome coronavirus
YJ Guo et al.
DNA AND CELL BIOLOGY (2005)
Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China
SS Chiu et al.
CLINICAL INFECTIOUS DISEASES (2005)
Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry
H Hofmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Antibody responses to individual proteins of SARS coronavirus and their neutralization activities
MF Qiu et al.
MICROBES AND INFECTION (2005)
Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2
WH Li et al.
EMBO JOURNAL (2005)
Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies
YX He et al.
JOURNAL OF IMMUNOLOGY (2005)
Identification of a novel coronavirus in bats
LLM Poon et al.
JOURNAL OF VIROLOGY (2005)
Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia
PCY Woo et al.
JOURNAL OF VIROLOGY (2005)
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice
H Bisht et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A previously undescribed coronavirus associated with respiratory disease in humans
RAM Fouchier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
ZY Yang et al.
NATURE (2004)
Identification of a new human coronavirus
L van der Hoek et al.
NATURE MEDICINE (2004)
Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments
FY Zeng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2
SK Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antibodies to SARS coronavirus in civets
CC Tu et al.
EMERGING INFECTIOUS DISEASES (2004)
Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity
UJ Buchholz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
A Bukreyev et al.
LANCET (2004)
Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
YX He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2
WH Li et al.
JOURNAL OF VIROLOGY (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003
NS Zhong et al.
LANCET (2003)
Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage
EJ Snijder et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
The genome sequence of the SARS-associated coronavirus
MA Marra et al.
SCIENCE (2003)
Characterization of a novel coronavirus associated with severe acute respiratory syndrome
PA Rota et al.
SCIENCE (2003)
Lung pathology of fatal severe acute respiratory syndrome
JM Nicholls et al.
LANCET (2003)
A novel coronavirus associated with severe acute respiratory syndrome
TG Ksiazek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
C Drosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
An outbreak of coronavirus OC43 respiratory infection in Normandy, France
A Vabret et al.
CLINICAL INFECTIOUS DISEASES (2003)
Rhinovirus and coronavirus infection-associated hospitalizations among older adults
AR Falsey et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Neuroinvasion by human respiratory coronaviruses
N Arbour et al.
JOURNAL OF VIROLOGY (2000)